Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.080
+0.200 (6.94%)
Mar 31, 2026, 4:00 PM EDT - Market closed
Altimmune Employees
Altimmune had 57 employees as of December 31, 2025. The number of employees decreased by 2 or -3.39% compared to the previous year.
Employees
57
Change (1Y)
-2
Growth (1Y)
-3.39%
Revenue / Employee
$719
Profits / Employee
-$1,545,491
Market Cap
400.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57 | -2 | -3.39% |
| Dec 31, 2024 | 59 | 0 | - |
| Dec 31, 2023 | 59 | 7 | 13.46% |
| Dec 31, 2022 | 52 | 5 | 10.64% |
| Dec 31, 2021 | 47 | 4 | 9.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Sutro Biopharma | 178 |
| Aura Biosciences | 113 |
| Century Therapeutics | 78 |
| Lineage Cell Therapeutics | 77 |
| Armata Pharmaceuticals | 60 |
| Lexeo Therapeutics | 59 |
ALT News
- 19 days ago - Altimmune: The High Cost Of Going Solo (Rating Downgrade) - Seeking Alpha
- 19 days ago - Altimmune, Inc. (ALT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - Altimmune, Inc. (ALT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates - GlobeNewsWire
- 4 weeks ago - Altimmune to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 - GlobeNewsWire
- 2 months ago - Obesity stocks slump on Novo's underwhelming 2026 sales forecast - Reuters
- 2 months ago - Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock - GlobeNewsWire